DRW Securities’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-3,207
| Closed | -$438K | – | 1158 |
|
|
2026
Q1 | $438K | Sell |
3,207
-817
| -20% | -$114K | 0.01% | 673 |
|
|
2025
Q4 | $494K | Sell |
4,024
-855
| -18% | -$104K | 0.01% | 471 |
|
|
2025
Q3 | $540K | Buy |
+4,879
| New | +$555K | 0.01% | 572 |
|
|
2025
Q2 | – | Sell |
-3,865
| Closed | -$433K | – | 1162 |
|
|
2025
Q1 | $433K | Buy |
+3,865
| New | +$399K | 0.01% | 361 |
|
|
2024
Q2 | – | Sell |
-8,356
| Closed | -$612K | – | 566 |
|
|
2024
Q1 | $612K | Buy |
+8,356
| New | +$643K | 0.02% | 213 |
|
|
2023
Q4 | – | Sell |
-3,869
| Closed | -$290K | – | 375 |
|
|
2023
Q3 | $290K | Sell |
3,869
-398
| -9% | -$30.6K | 0.01% | 271 |
|
|
2023
Q2 | $329K | Buy |
+4,267
| New | +$340K | 0.01% | 244 |
|
|
2021
Q3 | – | Sell |
-3,998
| Closed | -$275K | – | 301 |
|
|
2021
Q2 | $275K | Buy |
+3,998
| New | +$267K | 0.01% | 236 |
|
|
2020
Q4 | – | Sell |
-5,656
| Closed | -$357K | – | 159 |
|
|
2020
Q3 | $357K | Buy |
+5,656
| New | +$392K | 0.02% | 113 |
|
|
2020
Q2 | – | Sell |
-6,923
| Closed | -$518K | – | 231 |
|
|
2020
Q1 | $518K | Sell |
6,923
-1,406
| -17% | -$97.2K | 0.02% | 146 |
|
|
2019
Q4 | $541K | Buy |
+8,329
| New | +$542K | 0.02% | 119 |
|
|
2018
Q1 | – | Sell |
-18,312
| Closed | -$1.31M | – | 293 |
|
|
2017
Q4 | $1.31M | Buy |
+18,312
| New | +$1.39M | 0.14% | 96 |
|
|
2016
Q2 | – | Sell |
-17,500
| Closed | -$1.61M | – | 80 |
|
|
2016
Q1 | $1.61M | Buy |
+17,500
| New | +$1.58M | 0.1% | 33 |
|
|
2015
Q4 | – | Sell |
-51,000
| Closed | -$5.01M | – | 87 |
|
|
2015
Q3 | $5.01M | Buy |
+51,000
| New | +$5.66M | 0.55% | 9 |
|
|
2015
Q1 | – | Sell |
-65,000
| Closed | -$6.13M | – | 120 |
|
|
2014
Q4 | $6.13M | Buy |
+65,000
| New | +$6.72M | 0.7% | 23 |
|
|
2014
Q1 | – | Sell |
-73,259
| Closed | -$5.5M | – | 167 |
|
|
2013
Q4 | $5.5M | Buy |
73,259
+53,659
| +274% | +$3.74M | 0.23% | 18 |
|
|
2013
Q3 | $1.35M | Buy |
+19,600
| New | +$1.17M | 0.1% | 54 |
|
Other funds holding GILD
DRW Securities's GILD Position: Q2 2026 in Review
DRW Securities sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 3,207 shares — an estimated $438K sold.
DRW Securities first reported a position in GILD in Q3 2013 and held it in 17 quarters. The position peaked at $6.13M in Q4 2014. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- DRW Securities reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
- DRW Securities sold 3,207 Gilead Sciences shares in Q2 2026, an estimated $438K.
- DRW Securities first reported a position in Gilead Sciences in Q3 2013 and held it in 17 quarters.
- DRW Securities's Gilead Sciences position peaked at $6.13M in Q4 2014.
- 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on DRW Securities's 13F filing for Q2 2026, filed 14 Aug 2026.